DBV Technologies S.A. DBV.PA Stock
DBV Technologies S.A. Price Chart
DBV Technologies S.A. DBV.PA Financial and Trading Overview
| DBV Technologies S.A. stock price | 1.26 EUR |
| Previous Close | 3.43 EUR |
| Open | 3.46 EUR |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 3.43 - 3.77 EUR |
| 52 Week Range | 2.25 - 5.3 EUR |
| Volume | 102.47K EUR |
| Avg. Volume | 132.14K EUR |
| Market Cap | 351.5M EUR |
| Beta (5Y Monthly) | 1.184291 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.71 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6 EUR |
DBV.PA Valuation Measures
| Enterprise Value | 138.34M EUR |
| Trailing P/E | N/A |
| Forward P/E | -4.3232555 |
| PEG Ratio (5 yr expected) | 0.18 |
| Price/Sales (ttm) | 78.2509 |
| Price/Book (mrq) | 1.951706 |
| Enterprise Value/Revenue | 30.797 |
| Enterprise Value/EBITDA | -1.596 |
Trading Information
DBV Technologies S.A. Stock Price History
| Beta (5Y Monthly) | 1.184291 |
| 52-Week Change | -15.39% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 5.3 EUR |
| 52 Week Low | 2.25 EUR |
| 50-Day Moving Average | 3.24 EUR |
| 200-Day Moving Average | 3.12 EUR |
DBV.PA Share Statistics
| Avg. Volume (3 month) | 132.14K EUR |
| Avg. Daily Volume (10-Days) | 80.55K EUR |
| Shares Outstanding | 93.99M |
| Float | 31.36M |
| Short Ratio | N/A |
| % Held by Insiders | 6.50% |
| % Held by Institutions | 33.09% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -2249.019% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -36.027% |
| Return on Equity (ttm) | -76.68% |
Income Statement
| Revenue (ttm) | 4.49M EUR |
| Revenue Per Share (ttm) | 0.05 EUR |
| Quarterly Revenue Growth (yoy) | -13.80% |
| Gross Profit (ttm) | 4.84M EUR |
| EBITDA | -86667504 EUR |
| Net Income Avi to Common (ttm) | -100129000 EUR |
| Diluted EPS (ttm) | -1.08 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 192.29M EUR |
| Total Cash Per Share (mrq) | 2.05 EUR |
| Total Debt (mrq) | 2.6M EUR |
| Total Debt/Equity (mrq) | 1.45 EUR |
| Current Ratio (mrq) | 6.414 |
| Book Value Per Share (mrq) | 1.905 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -75024000 EUR |
| Levered Free Cash Flow (ttm) | -39472248 EUR |
Profile of DBV Technologies S.A.
| Country | France |
| State | N/A |
| City | Montrouge |
| Address | 177-181 Avenue Pierre Brossolette |
| ZIP | 92120 |
| Phone | 33 1 55 42 78 78 |
| Website | https://www.dbv-technologies.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 88 |
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies. The company is also developing Viaskin Milk that is in Phase I/II clinical trial for the treatment of immunoglobulin E (IgE) mediated cow's milk protein allergy (CMPA) and eosinophilic esophagitis. Its other earlier stage research programs include a vaccine for the respiratory syncytial virus, as well as treatments for Crohn's disease, celiac disease, and type I diabetes. The company has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Montrouge, France.
Q&A For DBV Technologies S.A. Stock
What is a current DBV.PA stock price?
DBV Technologies S.A. DBV.PA stock price today per share is 1.26 EUR.
How to purchase DBV Technologies S.A. stock?
You can buy DBV.PA shares on the Paris exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for DBV Technologies S.A.?
The stock symbol or ticker of DBV Technologies S.A. is DBV.PA.
Which industry does the DBV Technologies S.A. company belong to?
The DBV Technologies S.A. industry is Biotechnology.
How many shares does DBV Technologies S.A. have in circulation?
The max supply of DBV Technologies S.A. shares is 96.17M.
What is DBV Technologies S.A. Price to Earnings Ratio (PE Ratio)?
DBV Technologies S.A. PE Ratio is now.
What was DBV Technologies S.A. earnings per share over the trailing 12 months (TTM)?
DBV Technologies S.A. EPS is -0.71 EUR over the trailing 12 months.
Which sector does the DBV Technologies S.A. company belong to?
The DBV Technologies S.A. sector is Healthcare.
DBV Technologies S.A. DBV.PA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| SBF 120 SBF120 | 6059.85 EUR 6624.23 USD |
-0.18
|
— — | — — | — — | — - | — — |
| CAC Mid & Small MS190 | 14267.59 EUR 15596.4 USD |
-0.38
|
— — | — — | — — | — - | — — |
| NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
| CAC Mid 60 CM100 | 14640.46 EUR 16004 USD |
-0.34
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}